NCT01042379 2026-03-13
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2 Recruiting
Clinical Trials
11 trialsNCT07066189 2025-10-29
Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC
Yale University
Phase NA Recruiting
NCT07166185 2025-09-10
NEOTRAPSCAL
Blida 1 University
Recruiting
NCT06927180 2025-06-23
SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC
Henan Cancer Hospital
Phase 2 Recruiting
NCT05416164 2025-03-26
DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy
The Netherlands Cancer Institute
Phase NA Recruiting
NCT05976815 2025-03-26
KEYMOVE
University Institute of Maia
Phase NA Recruiting
NCT05918328 2025-03-07
Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC
Henan Cancer Hospital
Phase 2 Recruiting
NCT05350722 2024-12-30
ABLATIVE-2
Amsterdam UMC, location VUmc
Phase NA Recruiting
NCT06276868 2024-12-17
Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer
Henan Cancer Hospital
Phase 2 Recruiting
NCT05659056 2024-04-16
Neoadjuvant Study With Pyrotinib and Trastuzumab and Abraxane in Patients With HER2-enriched Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Recruiting
NCT05763992 2023-05-18
BREAKFAST-2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Recruiting